Poster Abstract Session:
210. Vaccinology
Saturday, October 20, 2012: 12:30 PM-2:00 PM
Room: SDCC Poster Hall F-H

Topical Category: I. Adult and Pediatric Vaccines and P. Pediatric and Perinatal Infections

Tracks: Adult ID, Pediatric ID

Presentations:

1742
Development of Multivalent Nasal Vaccine
Krishnakumar Duraisamy, Master of pharmacy ; Jaganathan KS, PhD ; Jagathesh Chandra Bose R, M.Pharmacy ; Kalaiyarasi D, M.Pharmacy

1743
Optimized Human Immune Cell Isolation for Application in Systems Vaccinology
Leigh Howard, MD ; Kristen Hoek, PhD ; Tara Allos ; Parimal Samir ; Xinnan Niu ; Kathryn Edwards, MD, FIDSA ; Andrew Link, PhD
Posters
  • poster_PedsRR_final.pdf (949.2 kB)
    		•

    1744
    A Proteomic Approach to Characterize Adjuvant-induced Secretome Profiles of Human Newborn and Adult Monocytes
    Djin-Ye Oh, MD, PhD ; David Dowling, PhD ; Tan Zhen ; Hanno Steen, PhD ; Ofer Levy

    1745
    Mucosal administration of nanoemulsion formulated RSV vaccine produces an enhanced Th17 response and reduced airway hyperreactivity
    Jakub Simon, MD, MS ; Nicholas Lukacs, PhD ; Tarek Hamouda, PhD, MD ; Andrzej Myc, PhD ; Paul Makidon, DVM, PhD ; Douglas Smith, PhD ; Vira Bitko, PhD ; Ali Fattom, PhD ; James Baker Jr., MD
    Posters
  • NanoBio IDSA Presentation 2012.pdf (90.1 kB)
    		•

    1746
    A Herpes Simplex Virus type 2 (HSV-2) ICP0- Vaccine Provides Increased Long Term Protection Compared to an Adjuvanted Glycoprotein D (gD2) Vaccine against Genital Herpes in Guinea Pigs
    David I. Bernstein, MD ; Julie Earwood, MS ; Jennifer Clark ; Fernando Bravo, MD ; William P. Halford, PhD ; Rhonda D. Cardin, PhD
    Posters
  • ICP0 DIB 56x36 10-10-12 FINAL .pdf (1.0 MB)
    		•

    CME Credits:


    See more of: Poster Abstract Session
    << Previous Session | Next Session >>

    Findings in the abstracts are embargoed until 12:01 a.m. PST, Oct. 17th with the exception of research findings presented at the IDWeek press conferences.